Monogram Biosciences, Inc., a life sciences company, engages in the development and commercialization of molecular diagnostic products focusing on infectious diseases, cancer, and other diseases. The company’s products for infectious diseases include PhenoSense HIV that directly and quantitatively measures resistance of a patient’s HIV to anti-viral drugs; GeneSeq HIV for examining and evaluating the genetic sequences of a patient’s HIV; PhenoSense GT; Replication Capacity HIV that measures viral fitness or the ability of a virus to reproduce and infect new cells; PhenoScreen for the identification of potential clinical drug candidates; and PhenoSense HIV Entry that...